Xbiome's proprietary drug development platform combines AI with gut microbiome technology, which expedites and increases the success rate of drug development.
Xbiome
Close
AsiaAI/Computing-Driven TherapeuticsArtificial IntelligenceBiotechnology
Yan Tan
Founder
Favorite Innovator
The Doctrine of the Mean